Lixte Biotechnology Holdings Inc (LIXT)
2.882
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
2.89
+0.01
(+0.27%)
After-Hours: 20:00
Lixte Biotechnology Holdings Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2016 | 0.1041M |
| September 30, 2016 | 0.5241M |
| June 30, 2016 | 0.0699M |
| March 31, 2016 | 0.446M |
| December 31, 2015 | 0.1096M |
| September 30, 2015 | 0.3696M |
| June 30, 2015 | 0.0696M |
| March 31, 2015 | -1.311M |
| December 31, 2014 | -0.2076M |
| September 30, 2014 | -0.8876M |
| June 30, 2014 | -1.188M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.075M |
| December 31, 2012 | 0.345M |
| September 30, 2012 | 0.795M |
| June 30, 2012 | 1.295M |
| March 31, 2012 | 1.520M |
| December 31, 2011 | 1.250M |
| Date | Value |
|---|---|
| September 30, 2011 | 0.9997M |
| June 30, 2011 | 0.7741M |
| March 31, 2011 | 0.474M |
| December 31, 2010 | -1.576M |
| September 30, 2010 | -1.801M |
| June 30, 2010 | -2.075M |
| March 31, 2010 | -2.075M |
| December 31, 2009 | -0.025M |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | -0.0003M |
| September 30, 2007 | -0.0005M |
| June 30, 2007 | -0.0005M |
| March 31, 2007 | -0.0005M |
| December 31, 2006 | -0.0005M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| iBio Inc | 8.285M |
| PAVmed Inc | 0.758M |
| PDS Biotechnology Corp | -- |
| Moleculin Biotech Inc | -0.124M |
| Syros Pharmaceuticals Inc | 37.34M |